Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Wockhardt shares trip over 14% on weak Q3 net

Wockhardt's net sales during the quarter under review were at Rs 1,075.77 crore, down 22.16 per cent from Rs 1,382.05 crore in the year-ago period.

It had posted a net profit of Rs 347.25 crore in the October-December quarter of 2014-15.
USFDA carried out inspections at manufacturing units situated at Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa).
UK Medicines and Healthcare Products Regulatory Agency has conducted a good manufacturing practice inspection of the company's plant at Goa.
In absolute terms, Indian companies could get only 13 first-time generic approvals out of 88 approvals in 2015, whereas the same was 21 out of 96 last year.
There is pressure by some sections within the US to downgrade India from 'watch list' to 'Priority foreign country'.
Swiss drug major Novartis had closed the transfer of the animal health business to US-based Eli Lilly globally in January last year.
While a total of 106 medicines have been added, 70 medicines have been deleted to finalise the new list.
Coolest Start UPs 2016